US Stocks
/
Myriad Genetics, Inc. Share Price
Myriad Genetics, Inc. Share Price

Myriad Genetics, Inc. Share Price

NASDAQ: MYGN | Small Cap
$4.31
+$0.11 (2.74%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Myriad Genetics, Inc. Stock Performance

Open
$4.16
Prev. Close
$4.20
Circuit Range
N/A
Day Range
$4.16 - $4.39
Year Range
$2.74 - $8.57
Volume
1,13,661
Average Traded
$4.31

Myriad Genetics, Inc. Share Price Today

As of 10 October 2026, Myriad Genetics, Inc.'s share price is $4.31. The stock opened at $4.16, compared to its previous close of $4.20. During today's trading session, Myriad Genetics, Inc.'s share price traded between $4.16 and $4.39, with an average price of $4.28. Over the past 52 weeks, the stock has recorded a high of $8.57 and a low of $2.74. In terms of performance, Myriad Genetics, Inc.'s share price has declined by 9.07% over the last six months and is down 46.32% on a year-on-year basis.

Myriad Genetics, Inc. Share Price Chart

$4.16$4.39
L
Show Current Price
H

Myriad Genetics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$399.11M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.18
Revenue (TTM)
$824.50B
Return On Equity (TTM)
-37.05%
Profit Margin
-44.38%
Debt to Equity
0.40
Quarterly Earnings Growth YoY
-57.66%

Myriad Genetics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$205.70$209.80$200.40$190.70
Net Profit-$27.40-$7.90-$34.10-$43.20
Net Profit Margin-13.32%-3.77%-17.02%-22.65%
Income ChangeN/A71.17%-331.65%-26.69%

Myriad Genetics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$678.40$753.20$837.60$824.50
Net Profit-$112.00-$263.30-$127.30-$365.90
Net Profit Margin-16.51%-34.96%-15.20%-44.38%
Income ChangeN/A-135.09%51.65%-187.43%

About Myriad Genetics, Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Myriad Genetics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.29
$4.33
+0.00%
Sep 2026
$2.94
$4.33
+36.22%
Aug 2026
$2.92
$3.17
+10.82%
Jul 2026
$5.78
$2.87
-49.78%
Jun 2026
$4.02
$5.71
+42.63%
May 2026
$4.72
$4.00
-15.61%
Apr 2026
$4.51
$4.74
+5.33%
Mar 2026
$5.08
$4.50
-2.60%
Feb 2026
$5.53
$4.62
-17.79%
Jan 2026
$6.20
$5.62
-8.62%
Dec 2025
$7.49
$6.15
-19.34%
Nov 2025
$8.28
$7.63
-5.03%

MYGN Share Price FAQs

What is Myriad Genetics, Inc. share price today?

chevron-up
Myriad Genetics, Inc. share price today is $4.31 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Myriad Genetics, Inc. stock?

chevron-up
The 52 week high of Myriad Genetics, Inc. stock is $8.57, while the 52 week low is $2.74 as of 10 Oct '26.

What is MYGN's market capitalisation today?

chevron-up
MYGN market capitalisation is $399.11M as of October 10, 2026, at 4:42 am IST.

What is MYGN's net income for the last quarter?

chevron-up
MYGN's net income for the last quarter is -43.20B USD.

What is the 5 year returns of MYGN?

chevron-up
The 5 year returns of MYGN is -85.99% as on 10 Oct '26.

What is the high & low stock price of MYGN today?

chevron-up
MYGN stock price hit a high of $4.39 and low of $4.16 as of 10 Oct '26.

Can I buy MYGN shares in India?

chevron-up
Yes. You can buy MYGN in India by opening an international trading account.